hausses nasdaq

Palmarès international : NASDAQ

    NYSE       Dow Jones    NASDAQ       Nasdaq 100    Londres       FTSE 100    Francfort    Xetra       DAX 30    Zurich       SMI    Milan       FTSE MIB    Madrid       IBEX 35    Amsterdam       AEX 25    Bruxelles       BEL 20    Lisbonne       PSI 20     Toutes les variations  Plus fortes hausses  Plus fortes baisses  Plus forts volumes     Aujourd'hui  Séance précédente  Depuis 1 semaine  Depuis 1 mois  Depuis 3 mois  Depuis 6 mois  Depuis le 1er janvier  Depuis 1 an  

Valeur	Dernier	Var. %	Ouv	+Haut	+Bas	Volumes*
Health Insuranc...	30,050	+539,36%	29,850	30,850	28,294	282 092
NF Energy Savin...	1,940	+90,20%	1,020	3,650	1,019	17 275 776
Geron Corporati...	4,340	+28,78%	3,910	4,470	3,800	25 978 891
Opiant Pharmace...	26,340	+27,55%	20,700	32,280	20,100	540 785
Heron Therapeut...	27,300	+26,98%	29,700	32,700	26,500	10 459 299
Innovate Biopha...	19,480	+22,52%	16,150	19,500	16,000	249 560
Avinger, Inc.	1,390	+16,81%	1,210	1,590	1,150	4 028 490
AKERS BIOSCIENC...	0,820	+15,95%	0,738	0,835	0,725	27 852 151
RISE Education ...	16,480	+14,92%	14,410	16,500	14,410	487 597
FC Global Realt...	0,850	+14,51%	0,804	0,910	0,790	16 791
Differential Br...	1,500	+13,64%	1,301	1,650	1,256	87 764
MediWound Ltd. ...	4,675	+12,65%	4,450	4,750	4,250	244 928
Fuel Tech, Inc.	1,450	+12,40%	1,300	1,450	1,300	101 141
HTG Molecular D...	5,560	+12,10%	4,960	5,650	4,900	2 728 542
SecureWorks Cor...	9,330	+12,00%	8,300	9,500	8,300	301 247
Cronos Group In...	8,750	+11,89%	8,120	8,750	8,100	6 627 221
ReTo Eco-Soluti...	8,490	+11,71%	7,750	8,830	7,670	300 105
Arcadia Bioscie...	45,690	+9,02%	49,520	53,550	38,860	2 401 726
Inspired Entert...	6,050	+9,01%	5,800	6,200	5,800	85 948
Novume Solution...	3,700	+8,82%	3,738	3,940	3,420	5 115
Cancer Genetics...	1,900	+8,57%	1,800	2,200	1,750	510 910
SGOCO Group, Lt...	1,240	+7,83%	1,150	1,470	1,140	352 796
Five Star Senio...	1,400	+7,69%	1,350	1,400	1,300	55 767
Aileron Therape...	9,110	+7,18%	8,790	9,219	8,510	81 966
Canadian Solar ...	16,600	+7,17%	16,335	16,940	15,950	2 530 332
ContraVir Pharm...	0,225	+7,00%	0,221	0,230	0,215	594 476
Raven Industrie...	35,950	+6,99%	33,750	36,050	33,650	233 148
Orbotech Ltd. -...	63,990	+6,83%	65,650	65,749	62,270	5 986 022
Everspin Techno...	8,460	+6,82%	7,970	8,520	7,900	148 687
Nightstar Thera...	14,430	+6,73%	13,680	14,605	13,480	20 569
Co-Diagnostics,...	2,250	+6,64%	2,111	2,322	2,109	22 930
Geospace Techno...	10,140	+6,62%	9,540	10,250	9,370	100 956
Madrigal Pharma...	121,190	+6,48%	112,590	121,340	111,140	636 515
Sienna Biopharm...	20,250	+6,47%	19,500	20,490	18,890	156 766
iRadimed Corpor...	14,550	+6,20%	13,805	14,650	13,805	10 107
Pieris Pharmace...	7,220	+6,02%	7,120	7,350	7,030	1 052 061
Hibbett Sports,...	23,250	+5,92%	22,000	23,250	21,750	1 151 607
Titan Pharmaceu...	1,080	+5,88%	1,010	1,233	1,000	335 558
Zumiez Inc.	23,400	+5,88%	22,350	23,650	22,150	860 896
ContraFect Corp...	2,010	+5,79%	1,900	2,010	1,800	126 366
ADMA Biologics ...	4,780	+5,75%	4,520	4,800	4,470	615 165
LongFin Corp	53,390	+5,72%	49,450	56,000	49,170	1 322 964
Gulf Island Fab...	8,400	+5,66%	7,750	8,400	7,700	116 546
Westmoreland Co...	0,518	+5,65%	0,425	0,520	0,425	908 012
Biostar Pharmac...	3,980	+5,57%	3,690	4,199	3,660	387 202
Synalloy Corpor...	15,250	+5,54%	14,850	15,250	14,500	9 654
Allied Motion T...	40,830	+5,50%	38,700	41,165	36,360	119 399
Appliance Recyc...	0,970	+5,43%	0,920	1,050	0,895	552 530
Teligent, Inc.	3,160	+5,33%	3,000	3,320	3,000	1 399 166
Amyris, Inc.	6,740	+5,31%

EYLEA DE REGENERON

Eylea de Regeneron montre des données prometteuses pour la rétinopathie diabétique

19/03/2018

Regeneron Pharmaceuticals a annoncé des résultats positifs de son essai clinique de phase III PANORAMA sur l'injection d'Eylea (aflibercept) dans la rétinopathie diabétique non proliférante modérément sévère à sévère.

Investorideas.com - Siding Demand to Reach 101.5 Million Squares in 2021

Investorideas.com - Siding Demand to Reach 101.5 Million Squares in 2021

Faire un petit don merci

Chers adeptes j'ai mis en place le bouton Paypal (don merci) pour soutenir mon blog de nouvelles s'il vous plaît faire un petit don

HERON THERAPEUTICS

Heron Therapeutics Inc. (HTRX) Is Surging On Phase 3 Study Results

3/19/2018 9:40 AM ET

Heron Therapeutics Inc. (HRTX) announced Monday morning that its Phase 3 studies of HTX-011 in subjects undergoing bunionectomy and hernia repair achieved all primary and key secondary endpoints.
Heron Therapeutics gapped open sharply higher Monday and is now up 8.35 at $29.85 on above average volume. The stock has surged to a new high for the year.